On 23.09.2019 EFSA published a reasoned opinion on the modification of MRLs for benalaxyl-M.
23rd September 2019
EFSA Article 12 review of benalaxyl-M
23September
17th September 2019
Article 12 MRL confirmatory data review for fluroxypyr
17September
On 17.09.2019 EFSA published a reasoned opinion on the modification of MRLs for fluroxypyr
17th September 2019
Fludioxonil, Article 12 confirmatory data review
On 17.09.2019 EFSA published a reasoned opinion (report 5812) on the evaluation of confirmatory data following the Article 12 review of MRLs for fludioxonil.
13th September 2019
EFSA Art. 12 MRL review pyridalyl
13September
On 13.09.2019 EFSA published a reasoned opinion on the review of existing MRLs for pyridalyl.
30th August 2019
EFSA Art. 12 MRL review emamectin
30August
On 29.08.2019 EFSA published a reasoned opinion on the review of existing MRLs for emamectin.
14th August 2019
Boscalid Article 12 confirmatory data review clock stopped
14August
On 14.8.2019 the clock was stopped on the Art. 12 MRL review of boscalid, because of an additional data request.
5th August 2019
EFSA Article 12 MRL confirmatory for oryzalin
05August
On 05.08.2019 EFSA published a reasoned opinion on the evaluation of confirmatory data following Article 12 of Regulation (EC) 396/2005 on MRLs for oryzalin.
29th July 2019
EFSA Art. 12 review of bupirimate MRLs
29July
On 29.7.2019 EFSA published its review of existing MRLs for bupirimate.
16th July 2019
EFSA Art. 12 MRL review fluopicolide
16July
On 16.07.2019 EFSA published a review (report 5748) of existing MRLs for fluopicolide according to Article 12 of Regulation (EC) No 396/2005.
30th May 2019
EFSA profoxydim Art.12 MRL review
30May
On 30.05.2018 EFSA published its reasoned opinion on the review of of existing MRLs for profoxydim according to Article 12 of Regulation 396/2005.
29th May 2019
EFSA mandipromamid Art. 12 MRL review
29May
On 29.05.2019 EFSA published the reasoned opinion on the review of existing MRLs for mandipropamid according to Article 12 of Regulation (EC) 396/2005.
12th February 2019
EFSA Statement on Art. 12 reviews
12February
On 12.02.2019 EFSA published a statement on the need to conduct Art. 12 MRL reviews for certain substances.
4th February 2019
EFSA MRL confirmatory data spinosad
04February
On 04.02.2019 EFSA published a reasoned opinion (report 5592) on confirmatory data submitted following the Art.12 review of spinosad.
4th February 2019
EFSA MRL confirmatory data flutolanil
On 04.02.2019 EFSA published a reasoned opinion (report 5593) on confirmatory data following the Art. 12 review of flutolanil.
31st January 2019
EFSA Art. 12 review imidacloprid
31January
On 31.01.2019 EFSA published its reasoned opinion on the Art. 12 review of the MRLs of imidacloprid.
31st January 2019
EFSA Art.12 review hexythiazox
On 31.01.2019 EFSA published its reasoned opinion of 12.12.2018 on a review of MRLs of hexythiazox.
15th January 2019
EFSA opinion dazomet MRLs
15January
On 15.01.2019 EFSA published a reasoned opinion on the Art. 12 MRL review of dazomet.
14th January 2019
EFSA Art.12 MRL review metam
14January
On 14.01.2019 EFSA published a reasoned opinion on the Art. 12 MRL review of metam.
14th January 2019
Fluometuron Art. 12 MRL review EFSA
On 14.01.2019 EFSA published a reasoned opinion on the Art. 12 MRL review of fluometuron.
8th January 2019
EFSA Art.12 review chromafenozide published
08January
On 08.01.2019 EFSA published a reasoned opinion on the Art. 12 MRL review for chromafenozide.